Ctcl During Immunomodulatory Treatment: Diagnostic Gaps and the Importance of Distinguishing Unmasking From True Onset: Comment on “Mycosis Fungoides Following Il-17 Inhibitor Treatment: A Case Series of Five Patients”

Ctcl During Immunomodulatory Treatment: Diagnostic Gaps and the Importance of Distinguishing Unmasking From True Onset: Comment on “Mycosis Fungoides Following Il-17 Inhibitor Treatment: A Case Series of Five Patients” Publisher Pubmed

Vahabi S M ; Ansari M S ; Etesami I ; Geller S ; Geskin L J

Source: Journal of Dermatology Published:2026

Style	Citing Format
MLA	Vahabi S M, et al.. "Ctcl During Immunomodulatory Treatment: Diagnostic Gaps and the Importance of Distinguishing Unmasking From True Onset: Comment on “Mycosis Fungoides Following Il-17 Inhibitor Treatment: A Case Series of Five Patients”." Journal of Dermatology, vol. 53, no. 9, 2026, pp. e770-e771.
APA	Vahabi S M, Ansari M S, Etesami I, Geller S, Geskin L J (2026). Ctcl During Immunomodulatory Treatment: Diagnostic Gaps and the Importance of Distinguishing Unmasking From True Onset: Comment on “Mycosis Fungoides Following Il-17 Inhibitor Treatment: A Case Series of Five Patients”. Journal of Dermatology, 53(9), e770-e771.
Chicago	Vahabi S M, Ansari M S, Etesami I, Geller S, Geskin L J. "Ctcl During Immunomodulatory Treatment: Diagnostic Gaps and the Importance of Distinguishing Unmasking From True Onset: Comment on “Mycosis Fungoides Following Il-17 Inhibitor Treatment: A Case Series of Five Patients”." Journal of Dermatology 53, no. 9 (2026): e770-e771.
Harvard	Vahabi S M et al. (2026) 'Ctcl During Immunomodulatory Treatment: Diagnostic Gaps and the Importance of Distinguishing Unmasking From True Onset: Comment on “Mycosis Fungoides Following Il-17 Inhibitor Treatment: A Case Series of Five Patients”', Journal of Dermatology, 53(9), pp. e770-e771.
Vancouver	Vahabi S M, Ansari M S, Etesami I, Geller S, Geskin L J. Ctcl During Immunomodulatory Treatment: Diagnostic Gaps and the Importance of Distinguishing Unmasking From True Onset: Comment on “Mycosis Fungoides Following Il-17 Inhibitor Treatment: A Case Series of Five Patients”. Journal of Dermatology. 2026;53(9):e770-e771.
BibTex	@article{ author = {Vahabi S M and Ansari M S and Etesami I and Geller S and Geskin L J}, title = {Ctcl During Immunomodulatory Treatment: Diagnostic Gaps and the Importance of Distinguishing Unmasking From True Onset: Comment on “Mycosis Fungoides Following Il-17 Inhibitor Treatment: A Case Series of Five Patients”}, journal = {Journal of Dermatology}, volume = {53}, number = {9}, pages = {e770-e771}, year = {2026} }
RIS	TY - JOUR AU - Vahabi S M AU - Ansari M S AU - Etesami I AU - Geller S AU - Geskin L J TI - Ctcl During Immunomodulatory Treatment: Diagnostic Gaps and the Importance of Distinguishing Unmasking From True Onset: Comment on “Mycosis Fungoides Following Il-17 Inhibitor Treatment: A Case Series of Five Patients” JO - Journal of Dermatology VL - 53 IS - 9 SP - e770 EP - e771 PY - 2026 ER -

Style

Citing Format

MLA

Vahabi S M, et al.. "Ctcl During Immunomodulatory Treatment: Diagnostic Gaps and the Importance of Distinguishing Unmasking From True Onset: Comment on “Mycosis Fungoides Following Il-17 Inhibitor Treatment: A Case Series of Five Patients”." Journal of Dermatology, vol. 53, no. 9, 2026, pp. e770-e771.

APA

Vahabi S M, Ansari M S, Etesami I, Geller S, Geskin L J (2026). Ctcl During Immunomodulatory Treatment: Diagnostic Gaps and the Importance of Distinguishing Unmasking From True Onset: Comment on “Mycosis Fungoides Following Il-17 Inhibitor Treatment: A Case Series of Five Patients”. Journal of Dermatology, 53(9), e770-e771.

Chicago

Vahabi S M, Ansari M S, Etesami I, Geller S, Geskin L J. "Ctcl During Immunomodulatory Treatment: Diagnostic Gaps and the Importance of Distinguishing Unmasking From True Onset: Comment on “Mycosis Fungoides Following Il-17 Inhibitor Treatment: A Case Series of Five Patients”." Journal of Dermatology 53, no. 9 (2026): e770-e771.

Harvard

Vahabi S M et al. (2026) 'Ctcl During Immunomodulatory Treatment: Diagnostic Gaps and the Importance of Distinguishing Unmasking From True Onset: Comment on “Mycosis Fungoides Following Il-17 Inhibitor Treatment: A Case Series of Five Patients”', Journal of Dermatology, 53(9), pp. e770-e771.

Vancouver

Vahabi S M, Ansari M S, Etesami I, Geller S, Geskin L J. Ctcl During Immunomodulatory Treatment: Diagnostic Gaps and the Importance of Distinguishing Unmasking From True Onset: Comment on “Mycosis Fungoides Following Il-17 Inhibitor Treatment: A Case Series of Five Patients”. Journal of Dermatology. 2026;53(9):e770-e771.

BibTex

@article{ author = {Vahabi S M and Ansari M S and Etesami I and Geller S and Geskin L J}, title = {Ctcl During Immunomodulatory Treatment: Diagnostic Gaps and the Importance of Distinguishing Unmasking From True Onset: Comment on “Mycosis Fungoides Following Il-17 Inhibitor Treatment: A Case Series of Five Patients”}, journal = {Journal of Dermatology}, volume = {53}, number = {9}, pages = {e770-e771}, year = {2026} }

RIS

TY - JOUR
AU - Vahabi S M
AU - Ansari M S
AU - Etesami I
AU - Geller S
AU - Geskin L J
TI - Ctcl During Immunomodulatory Treatment: Diagnostic Gaps and the Importance of Distinguishing Unmasking From True Onset: Comment on “Mycosis Fungoides Following Il-17 Inhibitor Treatment: A Case Series of Five Patients”
JO - Journal of Dermatology
VL - 53
IS - 9
SP - e770
EP - e771
PY - 2026
ER -

Science Communicator Platform

Authors